Reuters logo
1 个月前
BRIEF-Cytokinetics reports baseline data from first cohort of phase 2 clinical trial of ck-2127107 in patients with SMA
2017年7月5日 / 中午11点41分 / 1 个月前

BRIEF-Cytokinetics reports baseline data from first cohort of phase 2 clinical trial of ck-2127107 in patients with SMA

1 分钟阅读

July 5 (Reuters) - Cytokinetics Inc:

* Cytokinetics announces baseline data from first cohort of phase 2 clinical trial of ck-2127107 in patients with sma

* Cytokinetics -screen failures in cohort 1 primarily due to hfmse score that was either too high in ambulatory patients or too low in non-ambulatory patients

* Cytokinetics - there were no statistically significant differences otherwise in baseline demographics of enrolled patients compared to screen failures

* Cytokinetics - screen failures in cohort 1 primarily due to hfmse score that was either too high in ambulatory patients or too low in non-ambulatory patients Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below